Denso took part in a $71m series D round for artificial intelligence technology provider Blaize while inflammatory disease drug developer Aristea closed a $63m Novo and Arena-backed round.

Funding Blaize, a US-based developer of edge artificial intelligence technology, completed a $71m series D round yesterday co-led by Franklin Templeton and Temasek that included automotive component manufacturer Denso. Formerly known as ThinCI, the company had raised an undisclosed amount from Denso, peer Magna International and unnamed individuals in 2016, before Denso and its NSitexe…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.